Evidence map›Paper›PMID 20129051›Full record

ReviewMolecular cell2010

The CRISPR system: small RNA-guided defense in bacteria and archaea.

Fedor V Karginov, Gregory J Hannon

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 193 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
193citing papers in PubMed, 1 pooled it
20.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

193 citing papers in PubMed, 1 synthesis or guideline pooled it, 382 citations in OpenAlex.

  1. Statistical structure of host-phage interactions.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Quinolone Resistance and Zoonotic Potential ofAntibiotics (Basel, Switzerland) · 2025
    Article
  7. Review
  8. CRISPR/Cas9-TargetedJournal of developmental biology · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. A New RNA-Dependent Cas12g Nuclease.International journal of molecular sciences · 2023
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

133 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Fedor V KarginovWatson School of Biological Sciences, Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA. karginov@cshl.edu
Gregory J Hannon
Cold Spring Harbor Laboratory · US

Funding

VIRAL TRANSACTIVATIONP01CA013106 · NCI · COLD SPRING HARBOR LABORATORY · PI William Richard McCombie · 1985 to 2026
$116.8M
Howard Hughes Medical InstituteNCI NIH HHS P01 CA013106
6 · The paper itself

Abstract

All cellular systems evolve ways to combat predators and genomic parasites. In bacteria and archaea, numerous resistance mechanisms have developed against phage. Our understanding of this defensive repertoire has recently been expanded to include the CRISPR system of clustered, regularly interspaced short palindromic repeats. In this remarkable pathway, short sequence tags from invading genetic elements are actively incorporated into the host's CRISPR locus to be transcribed and processed into a set of small RNAs that guide the destruction of foreign genetic material. Here we review the inner workings of this adaptable and heritable immune system and draw comparisons to small RNA-guided defense mechanisms in eukaryotic cells.

Indexed as

Models, GeneticArchaeaBacteriaBacteriophagesEvolution, MolecularInverted Repeat SequencesRNA, ArchaealRNA, BacterialSequence Analysis, DNARNA, ArchaealRNA, Bacterial

Identifiers

PMID20129051
PMCPMC2819186
OpenAlexW2027591298

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.